In a major step forward, the FDA approved the first generic liraglutide for weight loss in August 2025, making these treatments more affordable
Important: Even though Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, Victoza, and Trulicity appear on its site, the MEDvidi support team confirmed that they are not prescribing injectable GLP-1s or compounded versions at this time (Nov 17, 2025)
For most women, this means the menopausal transition starts in their mid-40s
The other overhauls how your entire body processes food, hunger, and satiety
Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes-2025